Gene · 4595
Papers3,741
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
741 to 760 of 3,741
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Diagnosis and management of small bowel neuroendocrine tumors: A state-of-the-art. | World J Methodol | 2022 | 36186753 | PubTator, text mining | PubMed |
| Molecular factors, diagnosis and management of gastrointestinal tract neuroendocrine tumors: An update. | World J Clin Cases | 2022 | 36186187 | PubTator, text mining | PubMed |
| The DNA repair function of BCL11A suppresses senescence and promotes continued proliferation of triple-negative breast cancer cells. | NAR Cancer | 2022 | 36186110 | PubTator, text mining | PubMed |
| Methylation Analyses Reveal Promoter Hypermethylation as a Rare Cause of "Second Hit" in Germline BRCA1-Associated Pancreatic Ductal Adenocarcinoma. | Mol Diagn Ther | 2022 | 36178671 | PubTator, text mining | PubMed |
| Base excision repair accessory factors in senescence avoidance and resistance to treatments. | Cancer Drug Resist | 2022 | 36176767 | PubTator, text mining | PubMed |
| Neoantigens and their clinical applications in human gastrointestinal cancers. | World J Surg Oncol | 2022 | 36171610 | PubTator, text mining | PubMed |
| Dynamic features of human mitochondrial DNA maintenance and transcription. | Front Cell Dev Biol | 2022 | 36158192 | PubTator, text mining | PubMed |
| Landscape of Secondary Findings in Chinese Population: A Practice of ACMG SF v3.0 List. | J Pers Med | 2022 | 36143288 | PubTator, text mining | PubMed |
| Myosins and MyomiR Network in Patients with Obstructive Hypertrophic Cardiomyopathy. | Biomedicines | 2022 | 36140281 | PubTator, text mining | PubMed |
| Knockout and Inhibition of Ape1: Roles of Ape1 in Base Excision DNA Repair and Modulation of Gene Expression. | Antioxidants (Basel) | 2022 | 36139891 | PubTator, text mining | PubMed |
| Insights into Epigenetic Changes Related to Genetic Variants and Cells-of-Origin of Pancreatic Neuroendocrine Tumors: An Algorithm for Practical Workup. | Cancers (Basel) | 2022 | 36139607 | PubTator, text mining | PubMed |
| p53: From Fundamental Biology to Clinical Applications in Cancer. | Biology (Basel) | 2022 | 36138802 | PubTator, text mining | PubMed |
| Multiple Adenocarcinomas of the Small Bowel in a Patient with Brunner's Glands Agenesia: A Previously Unreported Association. | Clin Pract | 2022 | 36136863 | PubTator, text mining | PubMed |
| Clinical Utility of Universal Germline Genetic Testing for Patients With Breast Cancer. | JAMA Netw Open | 2022 | 36136330 | PubTator, text mining | PubMed |
| Prognostic Value of Pretreatment Neutrophil-to-Lymphocyte Ratio in HER2-Positive Metastatic Breast Cancer. | Curr Oncol | 2022 | 36135052 | PubTator, text mining | PubMed |
| Biclonal Desmoid-Type Fibromatosis With Two Beta-Catenin Mutations: Evidence for the Recruitment of Normal Myofibroblasts. | Cureus | 2022 | 36134040 | PubTator, text mining | PubMed |
| What can we learn from more than 1,000 Brazilian patients at risk of hereditary cancer? | Front Oncol | 2022 | 36132150 | PubTator, text mining | PubMed |
| The noncoding RNAs regulating pyroptosis in colon adenocarcinoma were derived from the construction of a ceRNA network and used to develop a prognostic model. | BMC Med Genomics | 2022 | 36127676 | PubTator, text mining | PubMed |
| Talazoparib, a Poly(ADP-ribose) Polymerase Inhibitor, for Metastatic Castration-resistant Prostate Cancer and DNA Damage Response Alterations: TALAPRO-1 Safety Analyses. | Oncologist | 2022 | 36124924 | PubTator, text mining | PubMed |
| Characterization of genetic predisposition to molecular subtypes of breast cancer in Brazilian patients. | Front Oncol | 2022 | 36119527 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4595/papers?page=38